Cure Pharmaceutical
在场
Cure Pharmaceutical 是一家在股票代码 CURR (US) 下上市的公司。
高管
查看带有其 8 名主要高管的组织结构图
Cure Pharmaceutical 搜索最多的简介
- Robert Davidson, Chief Executive Officer and Chairman of the Board
- Alan Preston, Director
- Mike Valentino, Chairman of the Board
创建提醒
跟踪 Cure Pharmaceutical 的高管变动
药店
Cure Pharmaceutical 拥有 1,831 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十二月5号)..
- Recursion Pharma and Exscientia have merged (公布2024十一月27号)..
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
药店 行业的其他推荐联系人
消息
Cure Pharmaceutical 的最新新闻稿
- CURE Pharmaceutical Letter to Shareholders - CURE Pharmaceutical
- CURE Pharmaceutical Reports Third Quarter 2022 Results With Strong Sequential and Year Over Year Revenue Increases and Continued High Margins - CURE Pharmaceutical
- Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV - CURE Pharmaceutical
- Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins - CURE Pharmaceutical
- CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman - CURE Pharmaceutical
- CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call - CURE Pharmaceutical
- CURE Pharmaceutical Announces the Appointment of New Board Member - CURE Pharmaceutical
- CURE Pharmaceutical Announces Teleconference With Investors - CURE Pharmaceutical
- CURE Pharmaceutical Announces the Sale of a Portion of its Platform Technology IP for $20 Million - CURE Pharmaceutical
- CURE Pharmaceutical Announces Positive Findings from Study at Cincinnati Children's Hospital Medical Center (CCHMC) Using CURE's Proprietary, Oral Thin Film (OTF) High, Single Dose Vitamin D in Pediatric Patients Pre- and Post-Hematopoietic Stem Cell Tran
- View more press releases Close
通过电子邮件
